Cthrc1	NN	Cthrc1 NN PennPOS
lowers	VBZ	lower VBZ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
collagen	NN	collagen NN PennPOS
associated	VBN	associate VBN PennPOS
with	IN	with pp NUPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
protects	VBZ	protect VBZ PennPOS
lung	NN	lung NN PennPOS
function	NN	function NN PennPOS
.	.	. . NUPOS

Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
involves	VBZ	involve VBZ PennPOS
collagen	NN	collagen NN PennPOS
deposition	NN	deposition NN PennPOS
that	WDT	that WDT PennPOS
results	VBZ	result VBZ PennPOS
in	IN	in IN PennPOS
a	DT	a dt NUPOS
progressive	JJ	progressive JJ PennPOS
decline	NN	decline NN PennPOS
in	IN	in IN PennPOS
lung	NN	lung NN PennPOS
function	NN	function NN PennPOS
.	.	. . NUPOS

This	DT	this d NUPOS
process	NN	process NN PennPOS
involves	VBZ	involve VBZ PennPOS
activation	NN	activation NN PennPOS
of	IN	of pp-f NUPOS
Smad2/3	NN	Smad2/3 NN PennPOS
by	IN	by IN PennPOS
transforming	VBG	transform VBG PennPOS
growth	NN	growth NN PennPOS
factor	NN	factor NN PennPOS
(	(	( ( NUPOS
TGF	NN	tgf NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
b	NN	b NN PennPOS
and	CC	and cc NUPOS
Wnt	NN	Wnt NN PennPOS
signaling	NN	signaling NN PennPOS
pathways	NNS	pathway n2 NUPOS
.	.	. . NUPOS

Collagen-Triple-Helix-Repeat-Containing-1	NN	Collagen-Triple-Helix-Repeat-Containing-1 NN PennPOS
(	(	( ( NUPOS
Cthrc1	NN	Cthrc1 NN PennPOS
)	)	) ) NUPOS
protein	NN	protein NN PennPOS
inhibits	VBZ	inhibit VBZ PennPOS
Smad2/3	NN	Smad2/3 NN PennPOS
activation	NN	activation NN PennPOS
.	.	. . NUPOS

To	TO	to p-acp NUPOS
test	VB	test VBP PennPOS
the	DT	the dt NUPOS
hypothesis	NN	hypothesis NN PennPOS
that	IN	that cst NUPOS
Cthrc1	NN	Cthrc1 NN PennPOS
limits	NNS	limit NNS PennPOS
collagen	NN	collagen NN PennPOS
deposition	NN	deposition NN PennPOS
and	CC	and cc NUPOS
the	DT	the dt NUPOS
decline	NN	decline NN PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
function	NN	function NN PennPOS
,	,	, , NUPOS
Cthrc1	NN	Cthrc1 NN PennPOS
knockout	NN	knockout NN PennPOS
(	(	( ( NUPOS
Cthrc1	NN	Cthrc1 NN PennPOS
(	(	( ( NUPOS
-	:	- : NUPOS
/	:	/ : NUPOS
-	:	- : NUPOS
)	)	) ) NUPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
wild-type	JJ	wild-type JJ PennPOS
mice	NNS	mouse n2 NUPOS
(	(	( ( NUPOS
WT	NN	wt NN PennPOS
)	)	) ) NUPOS
received	VBD	receive VBD PennPOS
intratracheal	JJ	intratracheal JJ PennPOS
injections	NNS	injection NNS PennPOS
of	IN	of pp-f NUPOS
2.5	CD	2.5 CD PennPOS
U/kg	NN	U/kg NN PennPOS
bleomycin	NN	bleomycin NN PennPOS
or	CC	or cc NUPOS
saline	NN	saline NN PennPOS
.	.	. . NUPOS

Lungs	NNS	lung NNS PennPOS
were	VBD	be vbd NUPOS
harvested	VBN	harvest VBN PennPOS
after	IN	after c-acp NUPOS
14	CD	14 crd NUPOS
days	NNS	day n2 NUPOS
and	CC	and cc NUPOS
Bronchoalveolar	JJ	bronchoalveolar JJ PennPOS
lavage	NN	lavage NN PennPOS
(	(	( ( NUPOS
BAL	NN	bal NN PennPOS
)	)	) ) NUPOS
TGF-b	NN	TGF-b NN PennPOS
,	,	, , NUPOS
IL1-b	NN	IL1-b NN PennPOS
,	,	, , NUPOS
hydroxyproline	NN	hydroxyproline NN PennPOS
and	CC	and cc NUPOS
lung	NN	lung NN PennPOS
compliance	NN	compliance NN PennPOS
were	VBD	be vbd NUPOS
assessed	VBN	assess VBN PennPOS
.	.	. . NUPOS

TGF-b	NN	TGF-b NN PennPOS
was	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
higher	JJR	high JJR PennPOS
in	IN	in IN PennPOS
Cthrc1	NN	Cthrc1 NN PennPOS
(	(	( ( NUPOS
-	:	- : NUPOS
/	:	/ : NUPOS
-	:	- : NUPOS
)	)	) ) NUPOS
compared	VBN	compare VBN PennPOS
to	TO	to p-acp NUPOS
WT	NNP	wt NN PennPOS
(	(	( ( NUPOS
53.45	CD	53.45 CD PennPOS
6.15	CD	6.15 CD PennPOS
ng/mL	NN	ng/mL NN PennPOS
vs.	CC	vs. CC PennPOS
34.48	CD	34.48 CD PennPOS
11.05	CD	11.05 CD PennPOS
)	)	) ) NUPOS
after	IN	after c-acp NUPOS
saline	NN	saline NN PennPOS
injection	NN	injection NN PennPOS
.	.	. . NUPOS

Bleomycin	NN	bleomycin NN PennPOS
injection	NN	injection NN PennPOS
increased	VBD	increase VBD PennPOS
TGF-b	NN	TGF-b NN PennPOS
in	IN	in IN PennPOS
both	CC	both CC PennPOS
Cthrc1	NN	Cthrc1 NN PennPOS
(	(	( ( NUPOS
-	:	- : NUPOS
/	:	/ : NUPOS
-	:	- : NUPOS
)	)	) ) NUPOS
(	(	( ( NUPOS
66.37	CD	66.37 CD PennPOS
8.54	CD	8.54 CD PennPOS
ng/mL	NN	ng/mL NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
WT	NN	wt NN PennPOS
(	(	( ( NUPOS
63.64	CD	63.64 CD PennPOS
8.09	CD	8.09 CD PennPOS
ng/mL	NN	ng/mL NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Hydroxyproline	NN	hydroxyproline NN PennPOS
was	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
higher	JJR	high JJR PennPOS
in	IN	in IN PennPOS
Cthrc1	NN	Cthrc1 NN PennPOS
(	(	( ( NUPOS
-	:	- : NUPOS
/	:	/ : NUPOS
-	:	- : NUPOS
)	)	) ) NUPOS
compared	VBN	compare VBN PennPOS
to	TO	to p-acp NUPOS
WT	NNP	wt NN PennPOS
after	IN	after c-acp NUPOS
bleomycin-injection	NN	bleomycin-injection NN PennPOS
(	(	( ( NUPOS
2.676	CD	2.676 CD PennPOS
0.527	CD	0.527 CD PennPOS
g/mg	NN	g/mg NN PennPOS
vs.	CC	vs. CC PennPOS
1.889	CD	1.889 CD PennPOS
0.520	CD	0.520 CD PennPOS
,	,	, , NUPOS
P	NN	p NN PennPOS
=	JJ	= JJ PennPOS
0.028	CD	0.028 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Immunohistochemistry	NN	immunohistochemistry NN PennPOS
of	IN	of pp-f NUPOS
Cthrc1	NN	Cthrc1 NN PennPOS
(	(	( ( NUPOS
-	:	- : NUPOS
/	:	/ : NUPOS
-	:	- : NUPOS
)	)	) ) NUPOS
lung	NN	lung NN PennPOS
sections	NNS	section NNS PennPOS
showed	VBD	show VBN PennPOS
intracellular	JJ	intracellular JJ PennPOS
localization	NN	localization NN PennPOS
and	CC	and cc NUPOS
activation	NN	activation NN PennPOS
of	IN	of pp-f NUPOS
b-catenin	NN	b-catenin NN PennPOS
Y654	NN	Y654 NN PennPOS
in	IN	in IN PennPOS
areas	NNS	area NNS PennPOS
of	IN	of pp-f NUPOS
tissue	NN	tissue NN PennPOS
remodeling	NN	remodeling NN PennPOS
that	WDT	that WDT PennPOS
was	VBD	be vbd NUPOS
not	RB	not xx NUPOS
evident	JJ	evident JJ PennPOS
in	IN	in IN PennPOS
WT	NNP	wt NN PennPOS
Lung	NN	lung NN PennPOS
compliance	NN	compliance NN PennPOS
was	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
reduced	VBN	reduce VBN PennPOS
by	IN	by IN PennPOS
bleomycin	NN	bleomycin NN PennPOS
in	IN	in IN PennPOS
Cthrc1	NN	Cthrc1 NN PennPOS
(	(	( ( NUPOS
-	:	- : NUPOS
/	:	/ : NUPOS
-	:	- : NUPOS
)	)	) ) NUPOS
but	CC	but cc-acp NUPOS
there	EX	there pc-acp NUPOS
was	VBD	be vbd NUPOS
no	DT	no dx NUPOS
effect	NN	effect NN PennPOS
in	IN	in IN PennPOS
WT	NNP	wt NN PennPOS
animals	NNS	animal NNS PennPOS
.	.	. . NUPOS

These	DT	these d NUPOS
data	NNS	datum NNS PennPOS
suggest	VBP	suggest VBP PennPOS
Cthrc1	NN	Cthrc1 NN PennPOS
reduces	VBZ	reduce VBZ PennPOS
fibrotic	JJ	fibrotic JJ PennPOS
tissue	NN	tissue NN PennPOS
formation	NN	formation NN PennPOS
in	IN	in IN PennPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
the	DT	the dt NUPOS
effect	NN	effect NN PennPOS
is	VBZ	be vbz NUPOS
potent	JJ	potent JJ PennPOS
enough	RB	enough RB PennPOS
to	TO	to p-acp NUPOS
limit	VB	limit VBP PennPOS
the	DT	the dt NUPOS
decline	NN	decline NN PennPOS
in	IN	in IN PennPOS
lung	NN	lung NN PennPOS
function	NN	function NN PennPOS
.	.	. . NUPOS

We	PRP	we pns12 NUPOS
conclude	VBP	conclude VBP PennPOS
that	IN	that cst NUPOS
Cthrc1	NN	Cthrc1 NN PennPOS
plays	VBZ	play VBZ PennPOS
a	DT	a dt NUPOS
protective	JJ	protective JJ PennPOS
role	NN	role NN PennPOS
,	,	, , NUPOS
limiting	VBG	limit VBG PennPOS
collagen	NN	collagen NN PennPOS
deposition	NN	deposition NN PennPOS
and	CC	and cc NUPOS
could	MD	can vmd NUPOS
form	VB	form VBP PennPOS
the	DT	the dt NUPOS
basis	NN	basis NN PennPOS
of	IN	of pp-f NUPOS
a	DT	a dt NUPOS
novel	JJ	novel JJ PennPOS
therapy	NN	therapy NN PennPOS
for	IN	for c-acp NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

